Science Daily -
20 Jan 2022 19:54
A study has found that patients with cancer who receive chemotherapy -- and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells -- may mount an inadequate immune response to COVID-19 vaccination.
Share this Article